Viewing Study NCT03952832


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-30 @ 8:54 PM
Study NCT ID: NCT03952832
Status: WITHDRAWN
Last Update Posted: 2019-11-14
First Post: 2019-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma
Sponsor: City of Hope Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 18458
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View